Immunome, Inc. (IMNM) vs Inspire Medical Systems, Inc. (INSP)

A side-by-side comparison of Immunome, Inc. and Inspire Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IMNM vs INSP

growth of $100 · dividends reinvested · last 6y
IMNM +57.4% (+7.9%/yr)INSP -44.0% (-9.2%/yr)IMNM compounded faster over this window
0100200300Start $100202120222023202420252026$157$56
IMNM INSP

IMNM vs INSP: by the numbers

  • •INSP is the larger company ($2.00B vs $1.97B market cap).
  • •INSP is profitable (15.03% net margin) while IMNM runs a net loss (-3059.99%).

Metrics side by side

Valuation

MetricIMNMINSP
P/E ratioN/A14.99
Forward P/EN/A57.98
P/S ratioN/A2.23
P/B ratio3.742.43
EV / EBITDAN/A26.68
FCF yieldN/A5.85%

Profitability

MetricIMNMINSP
Gross margin57.43%86.13%
Operating margin-3084.76%6.02%
Net margin-3059.99%15.03%
ROE-48.43%16.36%
ROIC-51.06%6.33%

Growth (annualized)

MetricIMNMINSP
Revenue CAGR (5Y)N/A38.69%
Total return CAGR (5Y)2.88%-21.38%

Frequently asked

Is IMNM or INSP more profitable?
INSP runs the higher net margin — IMNM at -3059.99% versus INSP at 15.03%.
How have IMNM and INSP total returns compared?
Over the past 5 years, IMNM delivered 2.88% and INSP delivered -21.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.